This grant is for the purpose of funding comprehensive human and animal research investigations into the pharmacokinetic (PK) and pharmacodynamic (PD) effects of ?9-tetrahydrocannabinol (THC) found in cannabis and cannabis products. The research aims to provide a deeper scientific understanding of how THC behaves in the body and its subsequent biological interactions. This includes both human clinical trials and animal studies to elucidate the fundamental mechanisms and effects of THC, thereby contributing vital knowledge to the field of cannabis research and public health.
Opportunity ID: 335592
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-22-028 |
| Funding Opportunity Title: | Pharmacokinetics (PK) and Pharmacodynamics (PD) of THC in Cannabis and Cannabis Products (R01 – Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Sep 08, 2021 |
| Last Updated Date: | Sep 08, 2021 |
| Original Closing Date for Applications: | Feb 09, 2022 |
| Current Closing Date for Applications: | Feb 09, 2022 |
| Archive Date: | Mar 17, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Independent school districts For profit organizations other than small businesses State governments Native American tribal organizations (other than Federally recognized tribal governments) Small businesses Private institutions of higher education Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) City or township governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to support human and animal research on the pharmacokinetic (PK) and pharmacodynamic (PD) effects of ?9-tetrahydrocannabinol (THC) that is present in cannabis and cannabis products. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-028.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 335592 Full Announcement-RFA-DA-22-028 -> RFA-DA-22-028-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00269826 | Jan 09, 2022 | Feb 09, 2022 | View |
Package 1
Mandatory forms
335592 RR_SF424_5_0-5.0.pdf
335592 PHS398_CoverPageSupplement_5_0-5.0.pdf
335592 RR_OtherProjectInfo_1_4-1.4.pdf
335592 PerformanceSite_4_0-4.0.pdf
335592 RR_KeyPersonExpanded_4_0-4.0.pdf
335592 PHS398_ResearchPlan_4_0-4.0.pdf
335592 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
335592 RR_Budget_3_0-3.0.pdf
335592 RR_SubawardBudget30_3_0-3.0.pdf
335592 PHS398_ModularBudget_1_2-1.2.pdf
335592 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
